Paracetamol use in pregnancy - caution over causal inference from available data
Nat Rev Endocrinol
.
2022 Mar;18(3):190.
doi: 10.1038/s41574-021-00606-x.
Authors
Sura Alwan
1
,
Elizabeth A Conover
2
,
Lorrie Harris-Sagaribay
3
,
Steven H Lamm
4
,
Sharon V Lavigne
5
,
Shari I Lusskin
6
,
Sarah G Obican
7
,
Alfred N Romeo
8
,
Anthony R Scialli
9
,
Katherine L Wisner
10
Affiliations
1
Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA. alwans@uw.edu.
2
Division of Clinical Genetics, Munroe Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA.
3
MotherToBaby North Carolina, Asheville, NC, USA.
4
Center for Epidemiology and Maternal-Child Health, Washington, DC, USA.
5
MotherToBaby Connecticut, Division of Medical Genetics, UConn Health, Farmington, CT, USA.
6
Department of Psychiatry and Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
7
Department of Obstetrics and Gynecology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
8
MotherToBaby Utah, Utah Department of Health, Salt Lake City, UT, USA.
9
Reproductive Toxicology Center, A Non-Profit Foundation, Washington, DC, USA.
10
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
PMID:
34907341
DOI:
10.1038/s41574-021-00606-x
No abstract available
Publication types
Letter
Comment
MeSH terms
Acetaminophen / adverse effects
Analgesics, Non-Narcotic* / adverse effects
Female
Humans
Pregnancy
Prenatal Exposure Delayed Effects*
Substances
Analgesics, Non-Narcotic
Acetaminophen